The life sciences and biotech industries are among the fastest-growing economies, with a focus on investments in technological health solutions. The sector is adopting technology to enhance patient care, lower costs, boost transparency, produce more, and discover novel treatments. It's important for stakeholders to understand that the industry is undergoing a transformation as a result of the digital era and that this involves more than just expediting the current process in a digital pipeline. To adopt business processes that weren't previously possible, it involves more than merely using software to carry out routine task. The goal of digital transformation is to create innovative plans for fundamentally changing current business procedures in a way that benefits the company.
The biopharmaceutical industry is undergoing a profound transformation driven by digital technologies, often referred to as Biopharma 4.0. This era of digitalization presents unprecedented opportunities to revolutionize research and development (R&D) processes, leading to accelerated drug discovery, enhanced operational efficiency, and improved patient outcomes.
To delve deeper into this transformative journey and explore strategies for successful implementation, we are pleased to announce IDBS Presents "Enabling Digital Transformation in R&D with Biopharma 4.0" conference in association with BlueTech Media.
Senior Vice President Discovery Services,
Syngene International Limited
Chief Scientific Officer,
Aurigene Oncology Limited
Fermentation R&D Head,
Biocon Ltd
Head of Biologicals Research & Development, Anthem Biosciences
Senior Vice President,
Microlabs Analytical Research Lab
Senior Director, Process Development and Manufacturing Sciences, Kemwell Biopharma
General Manager, Head of MSAT, Aragen Biologics
Senior Vice President & Head,
Shilpa Pharma Lifescience Limited
Vice President Managing Director Integrated Safety, IQVIA
R&D Director, Site Leader,
Life Sciences Group
Thermo Fisher Scientific, Inc.
Director - R&D and Manufacturing, Serum Institute of India
Assistant Director, Technology Transfer, R&D - Biotechnology Division, Lupin Ltd.
Former Head, Quality Control,
Haffkine Bio-Pharmaceutical Corporation ltd
Commercial Director- Asia, IDBS
Regional Sale Manager- India & SE ASIA, IDBS
Additional Director,
Serum Institute Of India
Asst General Manager, Gennova Biopharmaceuticals
Associate Research Director, Reliance Life Sciences
Asst. Director, Bio Assay Development (Biosimilar) Lupin Biotech
Chief Technology Officer - Biotechnology, Biophore India Pharmaceuticals Pvt. Limited
Sr. Data Scientist - Digital Products Development, IDBS
CEO, Urokul Institute, Ex Director, Haffkine Institute, Mumbai
.pdf.png/:/rs=h:114,cg:true,m/qt=q:95)
.pdf.png/:/rs=h:104,cg:true,m/qt=q:95)